Again,
All of this is based on looking back at treatment from the past 30 yrs and assuming treatment is not improving and will not improve. With known blood markers that are rarely found in cancer-free women, perhaps additional focus could be placed there in while continually improving therapies and low-dose imaging are developed. Significant changes in Her2 yesterday and Triple negative today suggest things may be moving at a speed that could benefit those who detect and treat their cancer earlier now. Last I heard, surgery with clean margins was the largest contributor to survival. That's a bit easier in the early stage.
Quote:
|
Early detection may just mean patients spend a longer time knowing they have cancer, and yet die at the same time they would have died anyway if the tumor had been diagnosed later. A decision to forgo cancer screening can be a reasonable option.
|
That line of thinking, if logical, could be applied to any age.